Abstract

BPX-501 Cells (Donor T Cells Transduced with iC9 Suicide Gene) Treatment Following TCR Alpha Beta Depleted Stem Cell Transplantation in Adults and Children with Hematological Disorders

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
T-Cell Depleted HLA-Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (haplo-HSCT) Followed By Donor Lymphocyte Infusion with T Cells Transduced with the Inducible Caspase 9 (iC9) Suicide Gene in Children with Hematological Malignancies
Barbarella Lucarelli ... Franco Locatelli
Blood | VOL. 128
Barbarella Lucarelli, et. al.Barbarella Lucarelli ... Franco Locatelli
02 Dec 2016
Clinical Outcome after Adoptive Infusion of BPX-501 Cells (donor T cells transduced with iC9 suicide gene) in Children Given Alpha/Beta T-Cell Depleted HLA-Haploidentical Hematopoietic Stem Cell Transplantation (haplo-HSCT): Preliminary Results of a Phase I-II Trial
Franco Locatelli ... Alice Bertaina
Blood | VOL. 126
Franco Locatelli, et. al.Franco Locatelli ... Alice Bertaina
03 Dec 2015
Wanted: Prospective Studies of Alternative Donors
Claudio G Brunstein
Biology of Blood and Marrow Transplantation | VOL. 21
Claudio G BrunsteinClaudio G Brunstein
15 Apr 2015
BPX-501 Cells (donor T cells transduced with iC9 suicide gene) Are Able to Clear Life-Threatening Viral Infections in Children with Primary Immune Deficiencies Given Alpha/Beta T-Cell Depleted HLA-Haploidentical Hematopoietic Stem Cell Transplantation (haplo-HSCT)
Barbarella Lucarelli ... Franco Locatelli
Blood | VOL. 126
Barbarella Lucarelli, et. al.Barbarella Lucarelli ... Franco Locatelli
03 Dec 2015
View more papers

More From: Biology of Blood and Marrow Transplantation

Paper Title
Journal
Date
Author
Allogeneic hematopoietic cell transplant for bone marrow failure or myelodysplastic syndrome in dyskeratosis congenita/telomere biology disorders: Single-center single-arm open-label trial of reduced intensity conditioning without radiation
Marketa Dimitrov ... Christen L Ebens
Biology of Blood and Marrow Transplantation | VOL. -
Marketa Dimitrov, et. al.Marketa Dimitrov ... Christen L Ebens
11 Jul 2024
Subsequent Malignancies after CD19-Targeted Chimeric Antigen Receptor T cells in Patients with Lymphoma
Rachel Lorenc ... Parastoo B Dahi
Biology of Blood and Marrow Transplantation | VOL. -
Rachel Lorenc, et. al.Rachel Lorenc ... Parastoo B Dahi
06 Jul 2024
Clinical Practice Recommendations for Hematopoietic Cell Transplantation and Cellular Therapies in Follicular Lymphoma: A Collaborative Effort on behalf of The American Society of Transplantation and Cellular Therapy and the European Society of Blood and Marrow Transplantation
Madiha Iqbal ... Mohamed A Kharfan-Dabaja
Biology of Blood and Marrow Transplantation | VOL. -
Madiha Iqbal, et. al.Madiha Iqbal ... Mohamed A Kharfan-Dabaja
05 Jul 2024
Pharmacokinetics of Briquilimab as a Conditioning Agent for Hematopoietic Stem Cell Transplantation in Patients with Severe Combined Immunodeficiency, Myelodysplastic Syndrome, or Acute Myeloid Leukemia
Dawoon Jung ... Jogarao V.S Gobburu
Biology of Blood and Marrow Transplantation | VOL. -
Dawoon Jung, et. al.Dawoon Jung ... Jogarao V.S Gobburu
05 Jul 2024
View more papers